Posted by Mumbai: o9 Solutions said that it will supply its next-generation platform to Samsung Bioepis and help to manage production and supply chain.
o9 Solutions provides AI-backed IBP ( integrated business planning ) platform. It will help Samsung Bioepis optimise its focus on development, clinical trial management and regulatory registration.
In terms of functions, the platform, also dubbed as ‘digital brain’ supports all planning phases, including long-term strategic planning to medium and short-term execution.
It will integrate into the client’s existing enterprise resource planning (ERP). And seamlessly providing efficiencies in supply chain management, financial management, and collaboration.
The integration of digital brain into Samsung Bioepis will allow the company to leverage AI and analytics to streamline commercial planning, revenue planning, and gap closure activities.
This conversion of data into knowledge will enable a better understanding of how best to drive initiatives from new products to marketing and pricing for incremental impact and an optimal mix of investment.
“Our SCM platform contract with Samsung Bioepis — is o9 Solutions’ first project with a biopharmaceutical company. We are very honoured,” said Chakri Gottemukkala, CEO – o9 Solutions.
“We will be actively supporting Samsung Bioepis in its efforts to enhance productivity and reduce costs by providing our solutions to manage and plan pharmaceutical manufacturing and distribution,” added Gottemukkala.